The QuickCool Advisory Board was founded in February 2016 to serve as a company-wide guidance forum for concepts and ideas during the development process to ensure the development of a product that is more innovative, intuitive and modern than traditional systems or methods currently on the market.
Hans Friberg is Professor of Anesthesiology at Lund University and Senior Consultant in Intensive Care and Head of Department at Skåne University Hospital. He and Tadeusz Wieloch, Professor of Neuroscience at Lund University, are the key members of QuickCool’s Advisory Board.
Professor Friberg is the chair of the board and a well-renowned key opinion leader within the field of therapeutic hypothermia. He is one of the investigators of the randomized international multi-center study "Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest", published in "The New England Journal of Medicine" (2013). The study showed that there was no significant difference in survival rate between cooling patients to 33°C or 36°C. However, the results were significant enough to result in new worldwide guidelines for cooling after a cardiac arrest. (Study link).
Professor Wieloch’s research team focuses on studies of mechanisms of brain damage after cardiac arrest and stroke, as well as mechanisms of functional recovery of the brain after injury. The research is conducted experimentally and translationally with a view to develop new therapies that prevent brain damage or improve brain function. He has published over 200 scientific articles in this field since 1981.
In parallel with establishing an Advisory Board, QuickCool has also established a User Advisory Network to ensure that user needs are met.
The core of the QuickCool User Advisory Network consists of professionals who have many years of experience in the field of TTM. This ensures that we have good insight into the day-to-day work and related clinical requirements.